Bioorganic and Medicinal Chemistry Letters p. 3541 - 3545 (2009)
Update date:2022-08-04
Topics:
Tice, Colin M.
Xu, Zhenrong
Yuan, Jing
Simpson, Robert D.
Cacatian, Salvacion T.
Flaherty, Patrick T.
Zhao, Wei
Guo, Joan
Ishchenko, Alexey
Singh, Suresh B.
Wu, Zhongren
Scott, Boyd B.
Bukhtiyarov, Yuri
Berbaum, Jennifer
Mason, Jennifer
Panemangalore, Reshma
Cappiello, Maria Grazia
Mueller, Dominik
Harrison, Richard K.
McGeehan, Gerard M.
Dillard, Lawrence W.
Baldwin, John J.
Claremon, David A.
Structure-based drug design led to the identification of a novel class of potent, low MW alkylamine renin inhibitors. Oral administration of lead compound 21l, with MW of 508 and IC50 of 0.47 nM, caused a sustained reduction in mean arterial bl
View MoreTaizhou Shengxing Chempharm Co.,Ltd
Contact:+86-576-88516600
Address:Yantou Chemical Zone Jiaojiang Taizhou Zhejiang China
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Contact:852-27701081
Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
Nanjing HuiBaiShi Biotechnology Co.,Ltd.
Contact:+86 (25)58745219
Address:No.606 Ningliu Road,LiuHe District.
Contact:86-310-8067016
Address:East Fuhua Road,Tiexi Chemical Industrial Estate,Hebei,China
Doi:10.1021/ja904575e
(2009)Doi:10.1016/S0040-4039(00)80218-X
(1988)Doi:10.1016/j.tetlet.2009.05.094
(2009)Doi:10.1002/adsc.200900080
(2009)Doi:10.1016/j.ica.2021.120409
(2021)Doi:10.1055/s-0029-1217169
(2009)